Insights

AI driven fCam Target pharmaceutical and agricultural AI drug discovery teams leveraging Evogene's ChemPass AI platform to shorten development timelines and reduce costs with generative design of small molecules.

Strategic partnerships Position Evogene as a partner for biotech and agrochemical companies seeking real-world innovation through integrated product development and collaboration, highlighting established partnerships as a value driver.

Real-World Innovation Emphasize Evogene's unique approach of combining science with market needs to create breakthrough products, offering a clear narrative for co-development opportunities and joint go-to-market strategies.

Financial signals Leverage the company’s funding level and modest revenue range to identify opportunities with staged collaboration, licensing, or milestone-based partnerships that align with their growth trajectory.

Tech stack leverage Propose cloud and devops aligned solutions (AWS, Google Cloud, Kubernetes) and data infrastructure services to optimize AI model training, data security, and collaboration across R&D teams engaged in small-molecule design.

Similar companies to Evogene

Evogene Tech Stack

Evogene uses 8 technology products and services including Amazon Web Services, Kubernetes, WordPress, and more. Explore Evogene's tech stack below.

Media & News

Evogene's Email Address Formats

Evogene uses at least 4 email formats:
Evogene Email FormatsExamplePercentage
First.Last@evogene.comJohn.Doe@evogene.com
79%
FirstL@evogene.comJohnD@evogene.com
13%
Last@evogene.comDoe@evogene.com
4%
First@evogene.comJohn@evogene.com
4%

Frequently Asked Questions

What is Evogene's phone number?

Minus sign iconPlus sign icon
You can contact Evogene's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Evogene's stock symbol?

Minus sign iconPlus sign icon
Evogene is a publicly traded company; the company's stock symbol is EVGN.

What is Evogene's official website and social media links?

Minus sign iconPlus sign icon
Evogene's official website is evogene.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Evogene generate?

Minus sign iconPlus sign icon
As of October 2026, Evogene's annual revenue is estimated to be $1M - $10M.

What is Evogene's SIC code and NAICS code?

Minus sign iconPlus sign icon
Evogene's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evogene have currently?

Minus sign iconPlus sign icon
As of October 2026, Evogene has approximately 101 employees across 4 continents, including Asia, North America and Europe. Key team members include Ceo: O. H., Chief Development Officer (cdo): G. T. and Chief Technology Officer: I. Z. Explore Evogene's employee directory with LeadIQ.

What industry does Evogene belong to?

Minus sign iconPlus sign icon
Evogene operates in the Biotechnology Research industry.

What technology does Evogene use?

Minus sign iconPlus sign icon
Evogene's tech stack includes Amazon Web Services, Kubernetes, WordPress, Jenkins, Shopify, Microsoft 365, Google Cloud and Google Search Console.

What is Evogene's email format?

Minus sign iconPlus sign icon
Evogene's email format typically follows the pattern of First.Last@evogene.com. Find more Evogene email formats with LeadIQ.

How much funding has Evogene raised to date?

Minus sign iconPlus sign icon
As of October 2026, Evogene has raised $115M in funding. The last funding round occurred on Sep 23, 2024 for $5.5M.

When was Evogene founded?

Minus sign iconPlus sign icon
Evogene was founded in 2002.
Evogene logo

Evogene

Biotechnology ResearchCentral District, Israel51-200 Employees

Evogene Ltd. is a biotechnology research company based in Rehovot, Israel, focused on computational chemistry and the generative design of small molecules for pharmaceutical and agricultural applications. Its flagship platform, ChemPass AI, is a proprietary engine that designs novel molecules optimized across multiple parameters to improve success rates and shorten development timelines. The firm pursues a Real-World Innovation approach, aligning scientific advances with concrete industry needs through partnerships and internal product development.

Its target markets include pharmaceutical and agricultural entities seeking faster, more cost-efficient development of small-molecule products. In June 2026, Evogene announced the successful completion of a first-in-human Phase 1 study of BMC128, a live bacterial product developed by its Biomica subsidiary, with favorable safety data and early signals of activity in combination with Nivolumab.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
EVGN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2002
Employees
51-200

Section iconFunding & Financials

  • $115M

    Evogene has raised a total of $115M of funding over 10 rounds. Their latest funding round was raised on Sep 23, 2024 in the amount of $5.5M as a Post IPO Equity.

  • $1M - $10M

    Evogene's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.